L1CAM and neoplasm: Specifically, L1CAM+ H-CTCs are significantly associated with lymph node metastasis, while L1CAM+ M-CTCs correlate with PR status, suggesting their potential involvement in tumor micrometastasis and hormone receptor-related pathways.